EUVIMEDEUVIMED entdecken
Crossref

Oligoclonal nanobody-based recombinant antivenom protects mice challenged with venom from cobras and king cobras from India

Arpan Samanta iD, Gotravalli V Rudresha iD, Shirin Ahmadi iD, Suthimon Thumtecho iD, Lars Boyens-Thiele iD, Tasja Wainani Ebersole iD, Nick J Burlet iD, Camilla Holst Dahl, Hmar Tlawmte Lalremsanga iD, Alexander K Buell iD, Anne Ljungars iD, Andreas H Laustsen iD und 1 weitere

Science Translational Medicine · 09.09.2026 · 18 (866)

DOI: 10.1126/scitranslmed.aed4290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 09.09.2026. Verfasst von Arpan Samanta und 12 weiteren Autor:innen. Beteiligte Einrichtung: Evolutionary Venomics Lab, Centre for Ecological Sciences, Indian Institute of Science, Bengaluru 560012, Karnataka, India. Hauptthemen laut MEDLINE: Antivenins, Elapid Venoms, Single-Domain Antibodies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Wellcome, DBT India Alliance, DFID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Snakebite envenoming causes more than 100,000 deaths annually, with India bearing nearly half of this burden. Current equine plasma–derived antivenoms suffer from variable efficacy, safety concerns, and limited cross-neutralization of geographically diverse venoms. Here, we report a rationally designed recombinant antivenom composed of five nanobodies (V H Hs) that target the α-neurotoxins, cytotoxins, and phospholipases A 2 prevalent in the venoms of cobra and king cobra species from India. These V H Hs were previously identified and functionally validated against homologous toxin families from African elapids. In murine preincubation and rescue models of snakebite envenoming, the cocktail prevented mortality after injection with venom from the monocled cobra ( Naja kaouthia ), both king cobra species ( Ophiophagus kaalinga and Ophiophagus hannah ) from the Western Ghats and Northeast India, and pan-Indian populations of spectacled cobra ( Naja naja ). These findings demonstrate the feasibility of developing broad-spectrum nanobody-based recombinant antivenoms with continent-wide coverage as a safe and regionally adaptable biologic for snakebite envenoming therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntiveninsElapid VenomsSingle-Domain AntibodiesAnimalsIndiaMiceRecombinant ProteinsElapidaeSnake BitesAmino Acid Sequence

Substanzen

AntiveninsElapid VenomsRecombinant ProteinsSingle-Domain Antibodies

Autor:innen und Institutionen

  • Evolutionary Venomics Lab, Centre for Ecological Sciences, Indian Institute of Science, Bengaluru 560012, Karnataka, India.
  • Department of Biotechnology and Biomedicine, Technical University of Denmark, DK-2800 Kongens Lyngby, Denmark.
  • Division of Toxicology, Department of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand.
  • Developmental Biology and Herpetology Laboratory, Department of Zoology, Mizoram University, Aizawl 796004, Mizoram, India.

ORCID-Profile: Arpan Samanta, Gotravalli V Rudresha, Shirin Ahmadi, Suthimon Thumtecho, Lars Boyens-Thiele, Tasja Wainani Ebersole, Nick J Burlet, Hmar Tlawmte Lalremsanga, Alexander K Buell, Anne Ljungars, Andreas H Laustsen, Kartik Sunagar

Förderung

  • Wellcome
  • DBT India Alliance
  • DFID

Zitieren

APA

Samanta, A., Rudresha, G. V., Ahmadi, S., Thumtecho, S., Boyens-Thiele, L., Ebersole, T. W., Burlet, N. J., Dahl, C. H., Lalremsanga, H. T., Buell, A. K., Ljungars, A., Laustsen, A. H., & Sunagar, K. (2026). Oligoclonal nanobody-based recombinant antivenom protects mice challenged with venom from cobras and king cobras from India. Science Translational Medicine, 18(866). https://doi.org/10.1126/scitranslmed.aed4290

Vancouver

Samanta A, Rudresha GV, Ahmadi S, Thumtecho S, Boyens-Thiele L, Ebersole TW, et al. Oligoclonal nanobody-based recombinant antivenom protects mice challenged with venom from cobras and king cobras from India. Science Translational Medicine. 2026;18(866). doi:10.1126/scitranslmed.aed4290

BibTeX
@article{Samanta2026,
  author = {Samanta, Arpan and Rudresha, Gotravalli V and Ahmadi, Shirin and Thumtecho, Suthimon and Boyens-Thiele, Lars and Ebersole, Tasja Wainani and Burlet, Nick J and Dahl, Camilla Holst and Lalremsanga, Hmar Tlawmte and Buell, Alexander K and Ljungars, Anne and Laustsen, Andreas H and Sunagar, Kartik},
  title = {Oligoclonal nanobody-based recombinant antivenom protects mice challenged with venom from cobras and king cobras from India},
  journal = {Science Translational Medicine},
  year = {2026},
  volume = {18},
  number = {866},
  doi = {10.1126/scitranslmed.aed4290}
}
Kostenlos starten →